HH-006
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for HH-006, covering 2026-04-07 to 2026-04-09. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Study to Evaluate the Efficacy and Safety of HH-006 in Patients With Chronic Hepatitis B Virus Infection [Phase 2]